Federated Hermes, Inc. Eagle Pharmaceuticals, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$4.26 - $6.51 $2,734 - $4,179	642 Added 54.04%	1,830 $9,000
Q4 2023 Jan 31, 2024	BUY	$4.63 - $15.21 $5,500 - $18,069	1,188 New	1,188 $6,000
Q2 2023 Aug 14, 2023	SELL	$17.74 - $31.87 $564,823 - $1.01 Million	-31,839 Reduced 47.46%	35,240 $685,000
Q1 2023 May 08, 2023	SELL	$25.06 - $34.09 $75,981 - $103,360	-3,032 Reduced 4.32%	67,079 $1.9 Million
Q4 2022 Feb 13, 2023	SELL	$24.98 - $39.77 $787,444 - $1.25 Million	-31,523 Reduced 31.02%	70,111 $2.05 Million
Q3 2022 Nov 14, 2022	SELL	$26.42 - $47.12 $784,832 - $1.4 Million	-29,706 Reduced 22.62%	101,634 $2.69 Million
Q2 2022 Aug 15, 2022	SELL	$41.26 - $51.35 $3,011 - $3,748	-73 Reduced 0.06%	131,340 $5.84 Million
Q1 2022 May 13, 2022	BUY	$44.58 - $52.6 $112,609 - $132,867	2,526 Added 1.96%	131,413 $6.5 Million
Q4 2021 Feb 14, 2022	BUY	$45.82 - $56.9 $8,476 - $10,526	185 Added 0.14%	128,887 $6.56 Million
Q3 2021 Nov 15, 2021	BUY	$43.79 - $55.78 $267,644 - $340,927	6,112 Added 4.99%	128,702 $7.18 Million
Q2 2021 Aug 16, 2021	SELL	$36.86 - $44.5 $156,986 - $189,525	-4,259 Reduced 3.36%	122,590 $5.25 Million
Q1 2021 May 13, 2021	BUY	$40.32 - $50.97 $1.49 Million - $1.89 Million	37,052 Added 41.26%	126,849 $5.3 Million
Q4 2020 Feb 12, 2021	BUY	$41.72 - $51.34 $1.44 Million - $1.77 Million	34,426 Added 62.17%	89,797 $4.18 Million
Q3 2020 Nov 12, 2020	BUY	$37.02 - $51.28 $2.05 Million - $2.84 Million	55,371 New	55,371 $2.35 Million
Q1 2020 May 13, 2020	SELL	$34.37 - $60.07 $272,622 - $476,475	-7,932 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$54.32 - $64.31 $1.58 Million - $1.87 Million	-29,118 Reduced 78.59%	7,932 $477,000
Q3 2019 Nov 14, 2019	SELL	$53.25 - $59.98 $3.26 Million - $3.68 Million	-61,305 Reduced 62.33%	37,050 $2.1 Million
Q2 2019 Aug 14, 2019	SELL	$46.61 - $58.45 $2.03 Million - $2.54 Million	-43,536 Reduced 30.68%	98,355 $5.48 Million
Q1 2019 May 10, 2019	BUY	$38.66 - $51.82 $4.2 Million - $5.63 Million	108,649 Added 326.84%	141,891 $7.16 Million
Q4 2018 Feb 13, 2019	BUY	$36.72 - $67.73 $1.22 Million - $2.25 Million	33,242 New	33,242 $1.34 Million
Q2 2018 Aug 10, 2018	SELL	$51.25 - $76.62 $447,053 - $668,356	-8,723 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$52.16 - $66.86 $454,991 - $583,219	8,723 New	8,723 $460,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account